statistiche ricercatore

Continente	#
NA - Nord America	916
EU - Europa	280
AS - Asia	272
SA - Sud America	46
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	6
OC - Oceania	6
Totale	1.551

Nazione	#
US - Stati Uniti d'America	883
SG - Singapore	88
IT - Italia	69
VN - Vietnam	66
CN - Cina	62
RU - Federazione Russa	58
BR - Brasile	32
DE - Germania	28
CA - Canada	24
FI - Finlandia	23
FR - Francia	19
GB - Regno Unito	17
SE - Svezia	16
IN - India	10
HK - Hong Kong	8
ID - Indonesia	8
LV - Lettonia	8
NL - Olanda	7
AR - Argentina	6
AU - Australia	6
KR - Corea	6
ES - Italia	5
IQ - Iraq	5
AT - Austria	4
CO - Colombia	4
CZ - Repubblica Ceca	4
MX - Messico	4
ZA - Sudafrica	4
BD - Bangladesh	3
BG - Bulgaria	3
CH - Svizzera	3
IL - Israele	3
PL - Polonia	3
SA - Arabia Saudita	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
BE - Belgio	2
LT - Lituania	2
PH - Filippine	2
RO - Romania	2
SK - Slovacchia (Repubblica Slovacca)	2
VE - Venezuela	2
CL - Cile	1
CR - Costa Rica	1
DK - Danimarca	1
EC - Ecuador	1
GP - Guadalupe	1
GT - Guatemala	1
IR - Iran	1
JM - Giamaica	1
JP - Giappone	1
KE - Kenya	1
KG - Kirghizistan	1
MA - Marocco	1
NI - Nicaragua	1
OM - Oman	1
PK - Pakistan	1
RS - Serbia	1
TH - Thailandia	1
Totale	1.526

Nome	#
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models	247
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface	246
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles	214
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine	210
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli	198
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform	178
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines	144
Rio1 downregulates centromeric RNA levels to promote the timely assembly of structurally fit kinetochores	114
Totale	1.551

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	85	0	0	0	6	7	6	2	13	11	11	9	20
2022/2023	126	20	13	8	23	4	15	2	11	11	1	8	10
2023/2024	83	2	3	8	3	3	26	6	7	2	10	2	11
2024/2025	239	2	2	25	52	7	32	5	18	2	57	23	14
2025/2026	538	54	16	60	79	51	37	114	13	56	37	12	9
2026/2027	142	11	17	42	72	0	0	0	0	0	0	0	0
Totale													1.551